TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Pharma Inc AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
177,974
|
172,785
|
138,635 |
| Financial expenses |
15,376
|
28,414
|
31,545 |
| Earnings before taxes |
33,613
|
22,460
|
29,900 |
| Total assets |
317,137
|
305,266
|
321,804 |
| Current assets |
139,106
|
104,565
|
110,996 |
| Current liabilities |
24,011
|
16,630
|
20,026 |
| Equity capital |
207,926
|
191,265
|
185,124 |
| - share capital |
17,575
|
18,504
|
19,715 |
| Employees (average) | 39 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.6%
|
62.7%
|
57.5% |
| Turnover per employee | 4,563 | ||
| Profit as a percentage of turnover |
18.9%
|
13.0%
|
21.6% |
| Return on assets (ROA) |
15.4%
|
16.7%
|
19.1% |
| Current ratio |
579.3%
|
628.8%
|
554.3% |
| Return on equity (ROE) |
16.2%
|
11.7%
|
16.2% |
| Change turnover |
13,863
|
42,668
|
14,994 |
| Change turnover % |
8%
|
33%
|
12% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.